Clinical Trials Directory

Trials / Completed

CompletedNCT05656391

Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis

Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The present study aimed to compare the in vivo prebiotic properties of bread produced by traditional breadmaking techniques with that made using a modern breadmaking method on Irritable Bowel Syndrome-like symptoms in patients with quiescent Ulcerative Colitis. The expected outcome of the differential effects was a change in the faecal microbiome composition, which may indicate changes in the mucosa-associated microbiota.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTreatment vs control breadConsumption of 200 grams per day of either treatment or control bread for eight weeks

Timeline

Start date
2019-12-16
Primary completion
2021-08-16
Completion
2021-08-16
First posted
2022-12-19
Last updated
2022-12-20

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05656391. Inclusion in this directory is not an endorsement.